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Introduction {#sec001}
============

Circadian rhythms in physiology and behaviour are in mammals generated from the suprachiasmatic nucleus (SCN), located in the ventral hypothalamus. The SCN consists of approximately 20,000 neurons and most of these neurons express a circadian clock, which is synchronized by internal neuronal signals to a coherent rhythm close to 24 h cycles \[[@pone.0232748.ref001], [@pone.0232748.ref002]\]. The molecular machinery of the biological clock consists of a group of clock genes, which by complex feedback interactions between the clock proteins drive circadian rhythmicity within neurons of the SCN (Mohawk and Takahashi, 2011; Mohawk et al., 2012). The endogenous period length of the circadian clock deviates slightly from 24 h and neurons of the SCN are therefore daily synchronized (entrained) to the astronomical day by light, which is the most important "zeitgeber" for entrainment (Golombek and Rosenstein, 2010). In mammals, light information for entrainment is transmitted from intrinsically photosensitive retinal ganglion cells (ipRGCs) containing the photoreceptor melanopsin, and by signals from the classical photoreceptors, the rods and cones \[[@pone.0232748.ref003], [@pone.0232748.ref004]\]. The ipRGCs project as the retinohypothalamic tract (RHT) to the brain, including the SCN, and provide light information for the entrainment process, negative masking and the pupillary light reflex \[[@pone.0232748.ref004], [@pone.0232748.ref005]\]. Two neurotransmitters, glutamate and PACAP, several subtypes of glutamate receptors and the PACAP type 1 receptor (PAC1), convey the light signals to the SCN neurons \[[@pone.0232748.ref006]--[@pone.0232748.ref008]\]. We have previously provided evidence that PACAP mediates synchronization of the SCN neurons via the PAC1 receptor targeting signaling pathways involving the immediate early gene (IEG) *Fos*, and the clock genes *Per1* and *Per2* \[[@pone.0232748.ref007], [@pone.0232748.ref009], [@pone.0232748.ref010]\]. Another IEG strongly induced in the SCN by light is NGFI-A, also known as *Egr1* (Early growth response protein 1), *zif*268 and *Krox*-24 \[[@pone.0232748.ref011]--[@pone.0232748.ref014]\]. Interestingly, PACAP has previously been shown to stimulate EGR1 expression in human neuroblastoma NB1-cells though PAC1 receptor/PKC/MEK1/2 signaling \[[@pone.0232748.ref015]\], and PACAP induced neuronal differentiation of PC12 cells requires EGR1 signaling pathways \[[@pone.0232748.ref016]\]. In the present study, we therefore investigated the role of PACAP in light induced expression of EGR1 in the mouse SCN by using quantitative in situ hybridization and immunohistochemistry on wild type and PACAP deficient mice light stimulated early or late subjective night at high (300 lux) or low (10 lux) light intensity.

Material and methods {#sec002}
====================

Animals {#sec003}
-------

64 PACAP wild type (+/+) and 64 PACAP deficient (-/-) mice (32 males and 32 females of each genotype, age 8--12 weeks when included in the study) were bred from heterozygote animals in a 129/Sv background \[[@pone.0232748.ref017]\]. Our strain of PACAP deficient mice was originally provided from Jim Wachek and Chris Colwell \[[@pone.0232748.ref018]\]. All animals included in the study were maintained in a 12:12 h light/dark (LD) cycle (light on at 6 a.m. = Zeitgeber (ZT) 0, lights off at 6 p.m. = ZT12) and housed in individual cages with food (Altromin 1324; Altromin Spezialfutter, Germany) and water ad libitum unless otherwise stated. Animals were treated according to the principles of Laboratory Animal Care (Law on Animal Experiments in Denmark, publication 382, June 10, 1987) and under Danish Veterinary Authorities (Dyreforsoegstilsynet) license no. 2008/561-1445. The animal research ethics committee (Dyreforsoegstilsynet) granted a formal waiver of ethics approval license no: 2017-15-0201-01364 to Jens Hannibal and thereby approved the study.

Light experiments {#sec004}
-----------------

For light-stimulation experiments, animals received a 30 min pulse of white light (\>300 lux or 10 lux) at ZT16 or ZT22. In experiments performed at ZT16 using 300 lux, animals were killed after 30, 60 and 120 min after initiation of the light pulse. Here we found equal *Egr1* induction in both groups of animals at all timepoints suggesting similar dynamics in PACAP knockout and wild type mice, and 60 min was hereafter chosen for the remaining experiments (see [Fig 1](#pone.0232748.g001){ref-type="fig"}). For in situ hybridization, animals (n = 12--16 in each group, equal number of sexes) receiving either a light pulse or kept as time matched darkness controls, were decapitated in dim red light (\<3 lux). For immunohistochemistry, light stimulated animals (n = 4 in each group) were killed and perfusion fixed in dim red light 60 min after the initiation of light exposure in Stefanini\'s fixative (2% PFA, 15% picric acid in 0.1 M PBS, pH 7.2) followed by immersion fixation in the same fixative overnight. Since we did not find any EGR1 immunoreactivity in the SCN of mice kept in darkness at the two time points (ZT17 and ZT23), comparison of EGR1 immunoreactivity in the SCN was done between light stimulated genotypes.

![Egr1 mRNA in SCN of wild type and PACAP deficient mice stimulated with 300 lux at ZT16.\
(A) Egr1 mRNA at ZT16:30 (30 min after initiation of the light pulse) and (B) at ZT18 (120 min after initiation of the light pulse). The quantities of Egr1 mRNA (digoxigenin labeled) are presented as group means (± SEM, n = 6--8 animals), and black bars represent wild type mice (controls) and white bars PACAP deficient mice. \*\*\* p\<0.001.](pone.0232748.g001){#pone.0232748.g001}

Light source and light intensity measurements {#sec005}
---------------------------------------------

White light was delivered by fluorescent tubes placed on top of the cages. The light intensity could be adjusted from 10--900 lux (measured at the top of the cages) via a resistence. The light intensity was set to either 300 (also used during ordinary housing) or 10 lux measured using an Advantest Optical Power meter TQ8210 (MetricTest, Hayward, CA), with measurements determined at setting of 514 nm; 300 lux (115.0 μW/cm^2^) and 10 lux (4.3 μW/cm^2^), respectively.

In situ hybridization histochemistry {#sec006}
------------------------------------

For detection of *Egr1* mRNA antisense, RNA probes were used. As template nucleotide 1--1978 (BC138615) excised as an EcoRI-fragment from IRCKp5014F0910Q (Source Bioscience, Nottingham, UK) and inserted in the SmaI site of pBluescriptKS+ was used. The resulting plasmid was linearized with HindIII for antisense and with BamHI for the sense probes, and transcription was done using T7 and T3-polymerase, respectively. In situ hybridization was performed using ^33^P-labeled probes (ZT17 and ZT23, both light intensities, and a 24 h LD serie, see [S1 Material](#pone.0232748.s002){ref-type="supplementary-material"} and [S1A Fig](#pone.0232748.s001){ref-type="supplementary-material"}) as previously described \[[@pone.0232748.ref019]\] or digoxigenin labeled probes \[[@pone.0232748.ref020]\] (see [S1 Material](#pone.0232748.s002){ref-type="supplementary-material"}). Briefly, the brains were cut on a cryostat in 12-μm-thick coronal sections through the SCN in three series of five slides with 3--4 sections on each slide. From each animal, one gelatin-coated slide from each series representing the rostral, mid, and caudal part of the SCN, respectively, was hybridized with the *Egr1* antisense probe. After hybridization and washing, slides hybridized with ^32^P-labeled probes were exposed to Amersham Hyperfilm (Amersham, DK) for 4--7 days. Autoradiograms were photographed by a DC200 camera and Q500MC Image Analysis System version 2.02A; Leica Cambridge, UK). The levels of *Egr1* mRNA in each animal at the rostral, mid, and caudal level of the SCN were quantified (qISH) with Fiji software as described previously \[[@pone.0232748.ref021]\] by measuring O.D. of the hybridization signals in the bilateral SCN. The measurements were corrected for nonspecific background by subtracting the grayscale values from a neighboring area (the optic chiasma) considered free of positive hybridization. The calculated mean of these measurements from each of the animals was used to calculate the group mean and SEM. Sections hybridized with digoxigenin labeled probes were analysed and the level of *Egr1* mRNA expression determined by Fiji/ImageJ and described previously \[[@pone.0232748.ref021]\] (see [Fig 2](#pone.0232748.g002){ref-type="fig"} and [S1 Material](#pone.0232748.s002){ref-type="supplementary-material"}). Hybridization was routinely performed in parallel using antisense and sense probes on sections from the same animal; no signal was obtained using the sense probe.

![*Egr1* mRNA (digoxigenin labeled probe) in the SCN in wild type (A, C) and PACAP deficient mice (B, D) at ZT16:30 (30 min after initiation of a 300 lux light pulse)(C, D) and control animals killed in darkness at ZT16:30 (A,B). Note the small group of cells weakly expressing *Egr1* mRNA in the central part of the central SCN in the dark controls. Throughout the study, *Egr1* mRNA was quantified in the central retinorecipient SCN \[[@pone.0232748.ref005]\] indicated by solid line. Dashed lines outline the entire mid SCN. Scale bars = 50 μm.](pone.0232748.g002){#pone.0232748.g002}

Immunohistochemistry (IHC) {#sec007}
--------------------------

### Tissue preparation {#sec008}

Before fixation, the animals were anesthetized using a subcutaneous injection of hypnorm and midazolam, 0.1 ml per 10 g of body weight. Hereafter, the animals were transcardially perfused with heparin (15,000 IE/L PBS, pH 7.2) for 3 minutes followed by Stefanini fixative for 15 minutes. All brains were post-fixed overnight in Stefanini fixative and cryoprotected in 30% sucrose prior to freezing (at -20°C).

Fixed brains were cut in a Leica CM3050S cryostat in 40-μm-thick free-flowing sections, as described previously \[[@pone.0232748.ref022]\] and stored at −21°C in cryoprotectant until processed. Brain sections were treated by antigen retrieval solution at 80°C for 1.5 h (DAKO ChemMate, Glostrup, Denmark, code No. S 203120 in distilled water, pH 6) and post-fixed in 4% PFA before processing for IHC. IHC was performed as previously described \[[@pone.0232748.ref023]\], using a rabbit anti-Egr-1 antibody (code no: SC-189, diluted 1:10.000, Santa Cruz Biotechnology, Inc.) and ENVISION® secondary antibody complex (Dako (K4002)). Finally, EGR1 was visualized by Alexa Fluor 488-conjugated tyramide (Molecular Probes, diluted 1:500). Control of EGR1 antibody specificity was confirmed by staining brain sections of light stimulated EGR1 knockout animals \[[@pone.0232748.ref024]\], which showed no staining.

Photomicrographs {#sec009}
----------------

Fluorescent images were obtained using an iMIC confocal microscope (Till Photonics, FEI, Germany) equipped with appropriate filter settings for detecting DAPI and Cy2/Alexa Fluor 488. The SCN was photographed with the iMIC confocal microscope using filter settings for Alexa488. Images from 40-micron thick brain sections were obtained as Z-stacks at X20 magnification and consist of 50 digital sections separated in the Z-level by 0.5 μm. Figures were shown as maximal projections in Fiji software (version 1.47q, NIH, USA) and mounted into plates using Adobe Illustrator CS5.

Statistics {#sec010}
----------

Statistics were performed using GraphPad Prism version 5.0. For comparison one-way Anova followed by Bonferroni's Multiple Comparison Test was used. P \< 0.05 was considered statistically significant.

Results {#sec011}
=======

EGR1 mRNA dynamic after light stimulation at night {#sec012}
--------------------------------------------------

Light induced EGR1 mRNA expression was significantly increased after a 30 min light pulse (300 lux) in both genotypes ([Fig 1A](#pone.0232748.g001){ref-type="fig"}). No difference was found between the two genotypes. 180 min after the light pulse at ZT16 EGR1 mRNA was almost at the level of the control animals not receiving the light pulse ([Fig 1B](#pone.0232748.g001){ref-type="fig"}) in the two genotypes. At ZT16:30 light induced EGR1 mRNA was located in the retinorecipient areas of the mouse SCN ([Fig 2](#pone.0232748.g002){ref-type="fig"}). A smaller number of neurons in the mid SCN demonstrated a low but distinct expression of EGR1 mRNA in the control animals (darkness) around ZT16-17 ([Fig 2A and 2B](#pone.0232748.g002){ref-type="fig"}).

Blunted light induced Egr1 mRNA in the SCN of PACAP deficient mice during low but not high light intensity at early night {#sec013}
-------------------------------------------------------------------------------------------------------------------------

We next examined the induction of EGR1 mRNA in wild type and PACAP deficient mice after a 30 min light pulse at early (ZT17) or late (ZT23) night at high (300 lux) and low (10 lux) light intensities. Theise timepoints were selected based on the observation that Egr1 mRNA expression was highest 60 min after light stimulation ([Fig 1](#pone.0232748.g001){ref-type="fig"} and [Fig 2](#pone.0232748.g002){ref-type="fig"} and [S1 Material](#pone.0232748.s002){ref-type="supplementary-material"}). In both genotypes Egr1 mRNA was significantly induced in the SCN after light stimulation at early night with 300 lux compared to the controls ([Fig 3A](#pone.0232748.g003){ref-type="fig"}). No differences were found between the wild type and PACAP deficient mice (p = ns) ([Fig 3A](#pone.0232748.g003){ref-type="fig"}). 10 lux (low) light intensity, induced Egr1 mRNA two-fold in the SCN compared to the controls ([Fig 3B](#pone.0232748.g003){ref-type="fig"}). PACAP deficient mice demonstrated, however, a severely blunted response to light stimulation compared to the wild type animals (p\<0.001) ([Fig 3B](#pone.0232748.g003){ref-type="fig"}). Immunohistochemical staining of EGR1 protein supported the Egr1 mRNA findings ([Fig 4](#pone.0232748.g004){ref-type="fig"}). At the timepoint examined, EGR1 immunoreactivity was found widespread in neurons of the core and shell of the SCN ([Fig 4](#pone.0232748.g004){ref-type="fig"}). At light intensity of 300 lux no difference was found in EGR1 expression in the SCN between the genotypes ([Fig 4A and 4B](#pone.0232748.g004){ref-type="fig"}). At low light intensity, EGR1 expression throughout the SCN was significantly blunted in PACAP deficient mice compared to that of wild type mice ([Fig 4C and 4D](#pone.0232748.g004){ref-type="fig"}).

![EGR1 mRNA (isotop labelled probe) in the SCN in wild type and PACAP deficient mice at early (ZT17) night light stimulated with 300 lux (A) and 10 lux (B) light intensity. EGR1 mRNA amounts are presented as group mean (± SEM, n = 8 animals) and wild type mice (controls) are shown in the black bars and PACAP deficient mice in the white bars. \*\*\* p\<0.001, \*\* p\<0.005, \* p\<0.05.](pone.0232748.g003){#pone.0232748.g003}

![Immunohistochemistry of coronal sections of the mid SCN stained for EGR1 protein at early night (ZT 17).\
The core and ventral shell (retinorecipient) and shell portion of the mid SCN \[[@pone.0232748.ref041]\] is indicated in panel C. Animals were fixed 60 min after a 30 min light stimulation at 300 lux (A and B) or 10 lux (C and D). OC, optic chiasm, Scale bars = 50 μm.](pone.0232748.g004){#pone.0232748.g004}

No difference in light induced Egr1 mRNA in the SCN of PACAP deficient and wild type mice at late night {#sec014}
-------------------------------------------------------------------------------------------------------

At late subjective night (ZT22) light at both high and low light intensity significantly induced Egr1 mRNA throughout the SCN in both wild type and PACAP deficient mice, and no difference was found between the two genotypes ([Fig 5](#pone.0232748.g005){ref-type="fig"}). Similarly, the light induced EGR1 immunoreactivity did not differ during neither high nor low light intensity.

![EGR1 mRNA (isotop labelled probe) in the SCN in wild type and PACAP deficient mice at late night light (ZT23) stimulated with 300 lux (A) or 10 lux (B) light intensity at ZT22. EGR1 mRNA amount is presented as group mean (± SEM, n = 8 animals) and results of wild type mice are shown in the black bars and PACAP deficient mice in the white bars. \*\*\* p\<0.001, \*\* p\<0.005, \* p\<0.05.](pone.0232748.g005){#pone.0232748.g005}

Discussion {#sec015}
==========

PACAP signaling via the PAC1 receptor has previously been shown to be involved in light entrainment and phase shift of the circadian rhythm in mice \[[@pone.0232748.ref008], [@pone.0232748.ref009], [@pone.0232748.ref018], [@pone.0232748.ref025], [@pone.0232748.ref026]\]. Mice lacking the PAC1 receptor or PACAP demonstrate smaller phase delay at early night, most likely due to altered light sensitivity with decreasing light intensities, while light mediated phase advances are less compromised at late night \[[@pone.0232748.ref008], [@pone.0232748.ref025]\]. PACAP signaling mechanism involved in altered phase shifting properties during early night involves induction of the expression of *Fos* and the two light responsive genes *Per1* and *Per2*. The induction is reduced in PAC1 mice compared to wild type mice after light stimulation at ZT16-17 \[[@pone.0232748.ref007], [@pone.0232748.ref009], [@pone.0232748.ref026], [@pone.0232748.ref027]\]. Furthermore, in vitro experiments with SCN brain slices have demonstrated a direct effect of PACAP on *Per1* and *Per2* gene expression in SCN neurons similar to that of light in intact animals \[[@pone.0232748.ref010]\]. In the present study, we found that PACAP signaling via the RHT is involved in light induction of EGR1 gene expression within neurons of the SCN. This induction was time and light intensity dependent and restricted to the early night at low light intensity. When examining the dynamic of Egr1 expression in the SCN at early night after a 30 min light pulse (300 lux) at ZT16, we found no difference between the two genotypes. Furthermore, these experiments also demonstrated that the highest level of EGR1 mRNA expression occurs 1 h after light stimulation, as reported previously by others \[[@pone.0232748.ref011]\]. At both early and late night, EGR1 expression is strongly induced by high light intensity and at late night at low light intensity, irrespectively of the presence of PACAP. PACAP is co-stored with glutamate in nerve terminals of the RHT \[[@pone.0232748.ref028], [@pone.0232748.ref029]\] and glutamate is considered to be the primary neurotransmitter of the RHT \[[@pone.0232748.ref006], [@pone.0232748.ref030]--[@pone.0232748.ref032]\]. It is likely that release of glutamate upon light stimulation at night mediates the induction of *Egr1* expression in the SCN neurons since glutamate is known to be a key stimulator of *Egr1* expression via activation of N-methyl-D-aspartate (NMDA) receptors \[[@pone.0232748.ref033]\]. NMDA stimulation results in elevation of intracellular Ca2+ and light like phase shifts which can be modulated by PACAP signaling \[[@pone.0232748.ref010], [@pone.0232748.ref034], [@pone.0232748.ref035]\]. The blunted induction of *Egr1* at low light intensity found in the present study suggests that EGR1 is involved in the modulating effect of PACAP on glutamate/NMDA signaling at early night.

A role of EGR1 in light induced phase shift is, however, not clarified. Although EGR1 is strongly induced by light at night, studies in mice lacking EGR1 revealed normal light entrainment and phase response to bright light during both early and late night \[[@pone.0232748.ref014], [@pone.0232748.ref024]\], and normal expression of FOS after nocturnal light stimulation \[[@pone.0232748.ref014]\]. In both studies, generalized EGR1 deficient mice were used and neither found difference in phase shifts between the wild type and EGR1 deficient mice stimulated with high light intensities, nor did we find change in light induced *Per1* response in the SCN \[[@pone.0232748.ref024]\]. Furthermore, we also examined the same mice at low light intensities (10 lux) and found no difference in phase shifts between the genotypes ([S1B Fig](#pone.0232748.s001){ref-type="supplementary-material"}). It is therefore likely that EGR1 induction in SCN neurons after light stimulation at night is not directly involved in light induced phase shifts (or light entrainment). In this study, generalized PACAP deficient mice were used, and we cannot exclude that our results can be affected by developmental changes in the KO mice.

EGR1 regulates many genes that have diverse cellular functions such as cell proliferation, cell growth, apoptosis, vascular functions, immune response, female reproduction, and learning and memory \[[@pone.0232748.ref036], [@pone.0232748.ref037]\]. Recently, EGR1 was shown to regulate NMDA dependent transcription of the postsynaptic density protein PSD-95 and trafficking of the α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR) in hippocampal primary neurons \[[@pone.0232748.ref038]\]. PSD-95 is diurnally expressed in the mouse SCN as other postsynaptic scaffolding proteins \[[@pone.0232748.ref039]\], and AMPAR play important roles in light induced phase shifts \[[@pone.0232748.ref040]\]. A role of PACAP as modulator of light NMDA/glutamate mediated neurotransmission via the transcription factor EGR1 in SCN neurons needs further investigation but place PACAP in a potential role shaping synaptic plasticity during the LD cycle and during light stimulation at night.

Supporting information {#sec016}
======================

###### 

\(A\) *Egr1* mRNA expression during a 24 h LD cycle. Values were analysed using one-anova followed by Bonferroni's Multiple Comparison Test. P \< 0.05 was considered statistically significant. Values are given as mean ± SEM (n = 8 in each group, 4 males and 4 females). (B) Light induced phase shifts in wild type (EGR1+/+, black) and EGR1 deficient (EGR1-/-, white) mice during early (ZT16) and late subjective (ZT23) night to a 30 minutes light stimulation (10 lux). Values are given as mean ± SEM (n = 7--13 in each group). NS: not significant using Mann-Whitney U test.
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Minor points:

1\. what\'s the light intensity of the housing condition?

2, how the intensity of the light pulse was measured? at cage top level? eye level of the animals?

3, what\'s the genetic background the animals? what\'s the rationale of light pulse at ZT17? (maximum phase delay on PRC? or around dead zone? for this strain?)

4\. in Figure 2, some double-label to delineate the boundary and subregion of the SCN will be helpful.

5\. the authors discussed the results of EGR1 KO, stating that \"EGR1 induction in SCN neurons after light stimulation at night is not directly involve din light induced phase shifts\". It\'s possible that in KO animals, some compensatory mechanisms could have occurred, which saved the animals from behavioral deficits, and had normal phase shifts. It could also be the case for PACAP KO. A conditioned KO would be a better model to test the role of these genes.

6\. For statistical analysis, a two factor ANOVA seems to be a better choice. Any reason/justification for using Mann-Whitney U test?

\*\*\*\*\*\*\*\*\*\*

6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: No

Reviewer \#3: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.

10.1371/journal.pone.0232748.r002

Author response to Decision Letter 0

9 Mar 2020

Reviewer \#1: The authors applied two methods to measure egr1 protein and RNA levels independently in SCN in response to light stimulation and concluded that egr1 induction in PACAP deficient mice is blunted only with low light at ZT17. Although the conclusion is solid, additional details will strengthen the results.

1\) Only one time point (60 min after initiation of light stimulation) was measured in all experiments. Is it possible that egr1 is induced with different dynamics instead of the response being dampened in mutant mice?

We have included new data in a supplementary file showing the Egr1 expression in wild type and PACAP knockout mice killed 30 min and 180 min after a 30 min light pulse starting at ZT16. These data show that there is no difference in Egr1 induction between the two groups neither before (30 min) nor later (180 min) than the chosen time-point indicating similar dynamics. These data are shown in a new suppl. Fig. 1 (panel A and B).

2\) Although egr1 signal is likely from neuron, no direct evidence in the paper confirmed this. A co-staining with neuron markers such as NeuN will help. In addition, IF in figure 2 does not include all conditions tested in Figure 1 and no quantification was shown.

In a manuscript in preparation (Riedel et al.), we address this question. This study investigates the population of neurons expressing EGR1 and whether these neurons co-store FOS. Furthermore, the EGR1 cells are phenotyped to be VIP, AVP, and neuroglobin expressing cells.

Reviewer \#2: The study reports that PACAP-deficient mice show a significant reduction in SCN EGR-1 expression in response to low-intensity but not high-intensity light pulses. Furthermore, this effect occurs at only one of two phases of the night during light cycles. The Discussion also argues that EGR-1 signaling does not serve a major or direct role in entrainment of the circadian clock to light.

Major concerns:

The report is brief but provides some additional information. The ability to induce SCN EGR-1 by light exposure has been reported previously. PACAP has an established role in the entrainment of the SCN clock to retinal light exposure. The role of EGR-1 in the SCN is not known, although it does serve important functions in hippocampal synaptic plasticity. This study suggests PACAP may not have a critical role in EGR-1 induction by light. It provides an incremental increase in knowledge about the light entrainment pathway. The manuscript discusses other studies in which EGR-1 was not found to play a large role in entrainment, but it does not contribute much additional evidence on this point.

The Kruskal--Wallis or a one-way ANOVA should be used here rather than the Mann-Whitney U-test because comparisons are made between multiple (four) groups. After the groups are compared properly, it will be possible to determine whether significant differences still exist.

As requested by you and another reviewer, we reanalyze all data using one-way ANOVA followed by Bonferroni's Multiple Comparison Test. Our revised analysis showed same results as reported in the initial manuscript. We have included all calculations in the supplementary material (statistics).

Minor concerns:

The source and nature of the PACAP-deficient mice was not stated.

Our strain of PACAP deficient mice was originally provided from Jim Wachek and Chris Colwell (UCLA). Now mentioned on p.4, l. 84.

Are these complete PACAP knockouts? Yes.

Do they have any other behavioral or physiological deficits? The change in the circadian system was reported by Colwell et al. Am J. Physiol. 2004.

What was the age of the mice used? 8-12 weeks when included in the study p. 4 l. 83 Although the text was very readable, some words were used incorrectly, for example:

Line 58, classically instead of classical. Has been corrected

Line 110, Lightning instead of light. Has been corrected

Line 150, Fixated instead of fixed. Has been corrected

Reviewer \#3: This study assessed the role of PACAP on light-induced EGR1 expression in the SCN. The results showed that PACAP deficiency resulted in blunted EGR1 induction following a 10 lux light pulse at ZT17 but had no effect on EGR1 induction after a 300 lux pulse at ZT17 or 23, or a 10 lux pulse at ZT23. Although the study was straightforward, there are a few limitations in the design of the study, which can be addressed by additional experiments to include more time points of sampling and more detailed analysis of the results.

Major points:

1\. Light-induced EGR1 was examined at a single time point following the light pulse. A time course should be established, and it will be more informative to look beyond a single time point to examine how the time course of EGR1 induction was affected by PACAP. For example, although PACAP seemed to have no effect at 60 minutes following a pulse at ZT23, there might be an effect at 30 minute or 90 minutes after the pulse.

We have included new data in a new supplementary file from wild type and PACAP knockout mice killed 30 min and 180 min after a 30 min light pulse starting at ZT16, which show similar induction in the two groups of animals at all three time-points, suggesting that the dynamic of induction is not changed in the knockout compared to wild type animals.

2\. Given the fact that PACAP is released from RHT terminals to the SCN, it would be more adequate to analyze the EGR1 induction by SCN subregions, i.e. the retinorecipient core region and the shell region of the SCN.

EGR1 expression induced after light stimulation occurs in the retinorecipient part of the SCN initial being most intense in the ventrolateral part. We added a new suppl. figure 2, which demonstrate the entire SCN and the area of the SCN where measurements were performed. The data are presented in the manuscript and in supplementary figs and text.

Minor points:

1\. what\'s the light intensity of the housing condition? During ordinary housing the light intensity is ...\...for intensities during light stimuli please see revised text p. 5, l. 117-122:

White light was delivered by fluorescent tubes placed on top of the cages. The light intensity could be adjusted from 10-900 lux (measured at the top of the cages) via a resistence. The light intensity was set to 300 and 10 lux measured using an Advantest Optical Power meter TQ8210 (MetricTest, Hayward, CA), with measurements determined at setting of 514 nm; 300 lux (115.0 µW/cm2) and 10 lux (4.3 µW/cm2), respectively.

2, how the intensity of the light pulse was measured? at cage top level? eye level of the animals? See above.

3, what\'s the genetic background the animals? 129/SV. This is now in the text p. 4, l. 84.

what\'s the rationale of light pulse at ZT17? (maximum phase delay on PRC? or around dead zone? for this strain?)

The light pulse was given at ZT16, which is resulting in the maximum phase delay on PRC; Colwell et al. Am J. Physiol. 2004. See above for the rationale of evaluation of EGR1 expression at ZT17.

4\. in Figure 2, some double-label to delineate the boundary and subregion of the SCN will be helpful.

We have added the boundaries of the ventral/central area of retinal projections and the dorsal medial part in a revised fig. 2, panel C (Abrahamson and Moore Brain Res. 2001).

5\. the authors discussed the results of EGR1 KO, stating that \"EGR1 induction in SCN neurons after light stimulation at night is not directly involved in light induced phase shifts\". It\'s possible that in KO animals, some compensatory mechanisms could have occurred, which saved the animals from behavioral deficits, and had normal phase shifts. It could also be the case for PACAP KO. A conditioned KO would be a better model to test the role of these genes

A conditioned KO would probably reveal whether compensatory mechanisms play a role, this or a model specifically knocking out PACAP in melanopsin RGCs would also be of interest to evaluate the role of PACAP in light entrainment, it is however not available in our laboratory.

6\. For statistical analysis, a two factor ANOVA seems to be a better choice. Any reason/justification for using Mann-Whitney U test?

As requested by you and one other reviewer, we reanalyzed all data using ANOVA followed by Bonferroni's Multiple Comparison Test. Our revised analysis showed the same results as reported in our initial manuscript. We now include all calculations in the supplementary material (statistics).
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PONE-D-19-28339R1

Altered light induced EGR1 expression in the SCN of PACAP deficient mice

PLOS ONE

Dear Dr. Hannibal,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Because reviewer \#1 wasn't available at this time, I asked reviewers \#2 and \#3 to review your revised manuscript. Although reviewer \#3 recommended accepting your revised manuscript, the reviewer \#2 indicated several suggestions. Please revise the manuscript according to those suggestions. The reviewer \#2 also suggested moving the figures in the supporting information to the main text (into the results section as actual figures). I believe this will make it easier to read, so please consider doing so.

We would appreciate receiving your revised manuscript by May 21 2020 11:59PM. When you are ready to submit your revision, log on to <https://www.editorialmanager.com/pone/> and select the \'Submissions Needing Revision\' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled \'Manuscript\'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Shin Yamazaki, Ph.D.

Section Editor

PLOS ONE

\[Note: HTML markup is below. Please do not edit.\]

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#2: (No Response)

Reviewer \#3: All comments have been addressed

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#2: Yes

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#2: Yes

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#2: Yes

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#2: Yes

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#2: Most suggested changes and concerns have been made or addressed.

As mentioned by another reviewer, there should be a mention that the results could be affected by a possible developmental change in the KO mice that compensated for the lack of PACAP.

Because there are only three figures, the authors should consider moving some of the results in the Supporting Information to the Results section.

The writing needs additional improvement. Throughout the text there was not enough attention to important details needed for clarity such as these:

In the Abstract use \'PACAP-induced\" and \"light-induced\".

In the Introduction:

line 53, Shouldn\'t \"derivates\" be \"deviates\"?

line 66, \"(IEGs)\" should be \"(IEG)\".

line 69, Should be \"PACAP has previously\".

line 109, \"fixated\" should be \"fixed\" here, in line 169, and elsewhere.

Describe the ingredients of Stefanini\'s fixative the first time it\'s mentioned.

line 134, \"digoxiginin\" should be \"digoxigenin\"

line 207, \"(p=\*\*\*)\" should be \"(p\<0.001)\"

Are Figures 1 and 2 from digoxigenin or isotopic results?

line 328, In the Figure 2 caption, instead of \"Ventral and central retinorecipient and dorsal portion of the mid SCN\" it would be more consistent with the cited reference to refer to this as the \"core and shell regions\" and described as such in the Results.

Reviewer \#3: (No Response)

\*\*\*\*\*\*\*\*\*\*

7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#2: No

Reviewer \#3: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.

10.1371/journal.pone.0232748.r004
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Dear Academic Editor Shin Yamazaki

Please receive our revised manuscript entitled:

Altered light induced EGR1 expression in the SCN of PACAP deficient mice

by

Casper Schwartz Riedel, Birgitte Georg, Jan Fahrenkrug and Jens Hannibal

We thank you and the two reviewers for the constructive comments. We have revised our manuscript by addressing all points raised by reviewer \#2. A point to point response can be found below.

We agree that some of the figures present as supplementary figures in the previous version of the manuscript could be placed in the main manuscript. We therefore added two-revised Fig. 1 and Fig.2 (original Suppl. Fig. 1 and parts of Suppl. Fig.2) into the revised version of the manuscript. Furthermore, we addressed all the minor points raised by reviewer \#2.

Our revised manuscript including a track-change version of the revised version and supplementary material, which has been uploaded at Manuscript Central. The manuscript follows the guidelines for manuscripts submitted to PloSOne. The manuscript has not been submitted elsewhere.

On behalf of the authors,

Yours sincerely,

Jens Hannibal, Associate Professor, MD., PhD., DMSc.

 

Reviewer \#2:

Most suggested changes and concerns have been made or addressed.

As mentioned by another reviewer, there should be a mention that the results could be affected by a possible developmental change in the KO mice that compensated for the lack of PACAP.

This is now mentioned in the discussion p. 10, l. 283: "In this study, generalized PACAP deficient mice were used, and we cannot exclude that our results can be affected by developmental changes in the KO mice."

Because there are only three figures, the authors should consider moving some of the results in the Supporting Information to the Results section.

We agree that some of the figures present as supplementary figures in the previous version of the manuscript could be placed in the main manuscript. We therefore added two-revised Fig. 1 and Fig.2 (original Suppl. Fig. 1 and parts of Suppl. Fig.2) into the revised version of the manuscript.

The writing needs additional improvement. Throughout the text there was not enough attention to important details needed for clarity such as these:

In the Abstract use \'PACAP-induced\" and \"light-induced\".

p.2. l. 32: "we used PACAP deficient mice to evaluate its role in light induced gene expression of EGR1 in SCN neurons during early (ZT17) and late (ZT23) subjective night at both high (300 lux) and low (10 lux) white light intensity"

.

In the Introduction:

line 53, Shouldn\'t \"derivates\" be \"deviates\"? yes, corrected!

line 66, \"(IEGs)\" should be \"(IEG)\". yes, corrected!

line 69, Should be \"PACAP has previously\". yes, corrected!

line 109, \"fixated\" should be \"fixed\" here, in line 169, and elsewhere. yes, corrected!

Describe the ingredients of Stefanini\'s fixative the first time it\'s mentioned. yes, corrected!

line 134, \"digoxiginin\" should be \"digoxigenin\" yes, corrected!

line 207, \"(p=\*\*\*)\" should be \"(p\<0.001)\" yes, corrected!

Are Figures 1 and 2 from digoxigenin or isotopic results? The revised Fig. 2 is digoxigenin and the revised fig. 3 and 5 are isotopic. This is now stated in the figure captions.

line 328, In the Figure 2 caption, instead of \"Ventral and central retinorecipient and dorsal portion of the mid SCN\" it would be more consistent with the cited reference to refer to this as the \"core and shell regions\" and described as such in the Results. yes, corrected!

10.1371/journal.pone.0232748.r005
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PONE-D-19-28339R2

Dear Dr. Hannibal,

We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.

Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.

Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at <https://www.editorialmanager.com/pone/>, click the \"Update My Information\" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at <authorbilling@plos.org>.

If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <onepress@plos.org>.

With kind regards,

Shin Yamazaki, Ph.D.

Section Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers\' comments:
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27 Apr 2020

PONE-D-19-28339R2

Altered light induced EGR1 expression in the SCN of PACAP deficient mice

Dear Dr. Hannibal:

I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <onepress@plos.org>.

For any other questions or concerns, please email <plosone@plos.org>.

Thank you for submitting your work to PLOS ONE.

With kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Shin Yamazaki

Section Editor

PLOS ONE
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